Abstract
The plasmid DNA pERilox4 containing the gene of the recombinant protein, which included the leader sequence and the oxytocinoyl lysine tetramer, was constructed. The high level of gene expression in E. coli was achieved. The method for purification of the recombinant protein and its isolation in the soluble form was developed. The conditions for digestion of the hybrid protein by trypsin and carboxypeptidase B were matched. The effective method for transformation of oxytocinic acid to oxytocin was worked out. The scheme suggested allowed obtaining oxytocin in high yield.
Keywords: oxytocin, hybrid protein enzymatic cleavage, c-terminal amide
Protein & Peptide Letters
Title: Production And Purification Of Recombinant Human Oxytocin Overexpressed As A Hybrid Protein In Escherichia Coli
Volume: 10 Issue: 4
Author(s): Roman S. Esipov, Larisa A. Chupova, Sergey V. Shvets, Dmitry V. Chuvikovsky, Alexandr I. Gurevich, Tatyana I. Muravyova and Anatoly I. Miroshnikov
Affiliation:
Keywords: oxytocin, hybrid protein enzymatic cleavage, c-terminal amide
Abstract: The plasmid DNA pERilox4 containing the gene of the recombinant protein, which included the leader sequence and the oxytocinoyl lysine tetramer, was constructed. The high level of gene expression in E. coli was achieved. The method for purification of the recombinant protein and its isolation in the soluble form was developed. The conditions for digestion of the hybrid protein by trypsin and carboxypeptidase B were matched. The effective method for transformation of oxytocinic acid to oxytocin was worked out. The scheme suggested allowed obtaining oxytocin in high yield.
Export Options
About this article
Cite this article as:
Esipov S. Roman, Chupova A. Larisa, Shvets V. Sergey, Chuvikovsky V. Dmitry, Gurevich I. Alexandr, Muravyova I. Tatyana and Miroshnikov I. Anatoly, Production And Purification Of Recombinant Human Oxytocin Overexpressed As A Hybrid Protein In Escherichia Coli, Protein & Peptide Letters 2003; 10 (4) . https://dx.doi.org/10.2174/0929866033478807
DOI https://dx.doi.org/10.2174/0929866033478807 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thrombotic Thrombocytopenic Purpura, from the Perspectives of a Pediatrician
Current Pediatric Reviews Infectious Burden: A New Risk Factor and Treatment Target for Atherosclerosis
Infectious Disorders - Drug Targets Antiglycolytic Activities of <i>Strobilanthes crispus</i> Active Fraction and its Bioactive Components on Triple-Negative Breast Cancer Cells <i>In Vitro</i>
Anti-Cancer Agents in Medicinal Chemistry Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells
Current Drug Targets Nucleic Acid-based Technologies in Therapy of Malignant Gliomas
Current Pharmaceutical Biotechnology Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets Prevention of Bronchopulmonary Dysplasia
Current Pediatric Reviews Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening COX-2 Inhibitors Celecoxib and Parecoxib: Valuable Options for Postoperative Pain Management
Current Topics in Medicinal Chemistry Electrochemistry in the Mimicry of Oxidative Drug Metabolism by Cytochrome P450s
Current Drug Metabolism Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Current Stem Cell Research & Therapy Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
Current Molecular Pharmacology Lipoproteins in Atherosclerosis Process
Current Medicinal Chemistry Obesity Therapy: How and Why?
Current Medicinal Chemistry Storage, Expression and Function of Fas Ligand, the Key Death Factor of Immune Cells
Current Medicinal Chemistry Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Current Drug Metabolism Current and Future Therapeutic Targets of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vitamin D Receptor Agonists: Opportunities and Challenges in Drug Discovery
Current Topics in Medicinal Chemistry A Review of the Three-Dimensional Cell Culture Technique: Approaches, Advantages and Applications
Current Stem Cell Research & Therapy